Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric andTeen Patients Allows Identifying Two Main Classes of Biological ProcessesInvolved and New Potential Therapeutic Targets
- PMID: 27013923
- PMCID: PMC4780474
- DOI: 10.2174/1389202916666151014222603
Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric andTeen Patients Allows Identifying Two Main Classes of Biological ProcessesInvolved and New Potential Therapeutic Targets
Abstract
Research on bladder neoplasms in pediatric and teen patients (BNPTP) has described 21 genes, which are variously involved in this disease and are mostly responsible for deregulated cell proliferation. However, due to the limited number of publications on this subject, it is still unclear what type of relationships there are among these genes and which are the chances that, while having different molecular functions, they i) act as downstream effector genes of well-known pro- or anti- proliferative stimuli and/or interplay with biochemical pathways having oncological relevance or ii) are specific and, possibly, early biomarkers of these pathologies. A Gene Ontology (GO)-based analysis showed that these 21 genes are involved in biological processes, which can be split into two main classes: cell regulation-based and differentiation/development-based. In order to understand the involvement/overlapping with main cancer-related pathways, we performed a meta-analysis dependent on the 189 oncogenic signatures of the Molecular Signatures Database (OSMSD) curated by the Broad Institute. We generated a binary matrix with 53 gene signatures having at least one hit; this analysis i) suggests that some genes of the original list show inconsistencies and might need to be experimentally re- assessed or evaluated as biomarkers (in particular, ACTA2) and ii) allows hypothesizing that important (proto)oncogenes (E2F3, ERBB2/HER2, CCND1, WNT1, and YAP1) and (putative) tumor suppressors (BRCA1, RBBP8/CTIP, and RB1-RBL2/p130) may participate in the onset of this disease or worsen the observed phenotype, thus expanding the list of possible molecular targets for the treatment of BNPTP.
Keywords: Bioinformatics; PubMed query.; biomedical modeling; gene set; neoplastic transformation.
Figures

Similar articles
-
Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer.Clin Epigenetics. 2018 Feb 6;10:15. doi: 10.1186/s13148-018-0447-6. eCollection 2018. Clin Epigenetics. 2018. PMID: 29445424 Free PMC article.
-
Prognostic value of CtIP/RBBP8 expression in breast cancer.Cancer Med. 2013 Dec;2(6):774-83. doi: 10.1002/cam4.141. Epub 2013 Oct 3. Cancer Med. 2013. PMID: 24403251 Free PMC article.
-
Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells--interplay of ErbB and IGF1 signalling through IGFBP3 regulation.BMC Cancer. 2010 Sep 14;10:490. doi: 10.1186/1471-2407-10-490. BMC Cancer. 2010. PMID: 20840765 Free PMC article.
-
Genetic and molecular markers of urothelial premalignancy and malignancy.Scand J Urol Nephrol Suppl. 2000;(205):82-93. doi: 10.1080/003655900750169338. Scand J Urol Nephrol Suppl. 2000. PMID: 11144907 Review.
-
Alterations of tumor suppressor genes in bladder cancer.Semin Diagn Pathol. 1997 May;14(2):123-32. Semin Diagn Pathol. 1997. PMID: 9179973 Review.
Cited by
-
Analyses of Transcriptomics Cell Signalling for Pre-Screening Applications in the Integrated Approach for Testing and Assessment of Non-Genotoxic Carcinogens.Int J Mol Sci. 2022 Oct 22;23(21):12718. doi: 10.3390/ijms232112718. Int J Mol Sci. 2022. PMID: 36361516 Free PMC article. Review.
-
Building the drug-GO function network to screen significant candidate drugs for myasthenia gravis.PLoS One. 2019 Apr 4;14(4):e0214857. doi: 10.1371/journal.pone.0214857. eCollection 2019. PLoS One. 2019. PMID: 30947317 Free PMC article.
References
-
- National Cancer Institute (NCI) http://www.cancer.gov . [(Accessed February 19,2015)].
-
- Vallasciani S., Marrocco G., Gulia C., Zangari A., Piergentili R. 2015. Bladder Cancer in Pediatric Patients. - PubMed
-
- Merguerian P.A., Cartwright L., Khoury A.E. Genitourinary rhabdomyosarcoma and other bladder tumors. In: Docimo SG, Canning DA, Khoury A.E., editors. The Kelalis–King–Belman Textbook of clinical pediatric urology. 2007. pp. 969–998.
-
- Javadpour N., Mostofi F.K. Primary epithelial tumors of the bladder in the first two decades of life. J. Urol. 1969;101(5):706–710. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous